<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous studies on <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">celiac</z:e> patients demonstrated that exposure to gliadin alters the motility of the upper gastrointestinal tract, leading to increased <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>No literature is available regarding the possible presence of specialized <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> of the esophagus as a consequence of <z:hpo ids='HP_0011010'>chronic</z:hpo> reflux in adult <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">celiac</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Our purpose was to evaluate endoscopically and histologically the esophagi of a group of untreated <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">celiac</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>We studied 60 celiac patients, 13 men and 47 women (mean age, 40 +/- 14 [SD] years; range, 18-80 years), at their first endoscopy (following a <z:mpath ids='MPATH_458'>normal</z:mpath> diet) </plain></SENT>
<SENT sid="4" pm="."><plain>The distal esophagus was evaluated and multiple biopsies were taken </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="1" ids="51686">Hematoxylin</z:chebi>-eosin and alcian blue stainings were performed </plain></SENT>
<SENT sid="6" pm="."><plain>A group of nonceliac, age- and sex-matched patients was used as a control </plain></SENT>
<SENT sid="7" pm="."><plain>We found <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> in the distal esophagus of 16 of 60 (26.6%) <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">celiacs</z:e> (mean age, 45 +/- 13 years; range, 27-75 years), in comparison with a control-group prevalence of 10.9% (OR, 3.9; 95% CI, 1.4-11.2%) </plain></SENT>
<SENT sid="8" pm="."><plain>Among the <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">celiac</z:e> group with <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, only one patient had reflux-like symptoms </plain></SENT>
<SENT sid="9" pm="."><plain>None had <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, we observed an increased prevalence of esophageal <z:mpath ids='MPATH_160'>metaplasia</z:mpath> in patients with <z:hpo ids='HP_0002608'>celiac disease</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>This finding could be the result of motor abnormalities leading to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e>, combined with a mucosa which is sensitive to gliadin </plain></SENT>
</text></document>